Literature DB >> 2012031

Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis.

G Saggese1, S Bertelloni, G I Baroncelli, G Perri, A Calderazzi.   

Abstract

Idiopathic juvenile osteoporosis is a rare cause of osteoporosis during childhood. We examined four children (three boys and one girl, ranging in age from 2.3 to 12.6 years) with idiopathic juvenile osteoporosis. All of these patients had normal serum calcium, ionized calcium, phosphate, magnesium, 25-hydroxyvitamin D, intact parathyroid hormone, and total and extractable calcitonin levels. 1,25-Dihydroxyvitamin D values were low in three patients and slightly decreased in one. Three children were treated with calcitriol (1,25-dihydroxycholecalciferol) (0.50 micrograms/d in two and 0.25 microgram/d in the other). The fourth patient was not treated because of parental refusal. Therapy reduced the fracture rate. Follow-up at 6 and 12 months showed a significant increase in bone mineralization, which reached normal values in two children after 12 months of treatment. No side effects of calcitriol therapy were observed. The untreated patient did not show an improvement of bone mineralization in the same time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012031     DOI: 10.1001/archpedi.1991.02160040119019

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Intravenous pamidronate in juvenile osteoporosis.

Authors:  N J Shaw; C M Boivin; N J Crabtree
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

Review 3.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 4.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

5.  Idiopathic juvenile osteoporosis: evidence of normal osteoblast function by 1,25-dihydroxyvitamin D3 stimulation test.

Authors:  S Bertelloni; G I Baroncelli; G Di Nero; G Saggese
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

Review 6.  Calcium supplementation for improving bone mineral density in children.

Authors:  T M Winzenberg; K Shaw; J Fryer; G Jones
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 7.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

8.  Idiopathic juvenile osteoporosis: A case report and review of the literature.

Authors:  Ahmet Imerci; Umut Canbek; Sema Haghari; Levent Sürer; Muge Kocak
Journal:  Int J Surg Case Rep       Date:  2015-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.